Nitric oxide (NO) signaling as a potential therapeutic modality against psychostimulants.

Current pharmaceutical design

Volumn 19, Issue 40, 2013, Pages 7092-7102

  Liddie, Shervin ^a   Balda, Mara A ^b   Itzhak, Yossef ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; METHAMPHETAMINE; NITRIC OXIDE;

ANIMAL; COCAINE DEPENDENCE; DRUG ABUSE; DRUG DESIGN; DRUG EFFECT; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW; REWARD; SIGNAL TRANSDUCTION;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; COCAINE-RELATED DISORDERS; DOPAMINE; DRUG DESIGN; HUMANS; METHAMPHETAMINE; NITRIC OXIDE; REWARD; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84906795690     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161281940131209144527     Document Type: Review

References (0)